Coral Laboratories submits copy of statement of deviation or variation

Coral Laboratories has submitted a copy of the statement of deviation or variation in public issue, rights issue, preferential issue etc. for the quarter ended September 30, 2016 under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.